CJ
PRCT icon

Caitlin John’s Procept Biorobotics PRCT Stock Holding History

Caitlin John’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$375 Hold
15
– – ﹤0.01% 876
2025
Q4 		$472 Hold
15
– – ﹤0.01% 856
2025
Q3 		$535 Buy
+15
New +$685 ﹤0.01% 818

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Caitlin John's PRCT Position: Q1 2026 in Review

Caitlin John held its Procept Biorobotics (PRCT) position steady in Q1 2026 at 15 shares worth $375. The position accounts for ﹤0.01% of the portfolio, ranked #876.

Caitlin John first reported a position in PRCT in Q3 2025 and has held it in 3 quarters since. The position peaked at $535 in Q3 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Caitlin John held 15 shares of Procept Biorobotics worth $375 as of Q1 2026.
  • Caitlin John left its Procept Biorobotics share count unchanged in Q1 2026.
  • Procept Biorobotics made up ﹤0.01% of Caitlin John's portfolio in Q1 2026, its #876 holding.
  • Caitlin John first reported a position in Procept Biorobotics in Q3 2025 and has held it in 3 quarters since.
  • Caitlin John's Procept Biorobotics position peaked at $535 in Q3 2025.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Caitlin John's 13F filing for Q1 2026, filed 13 May 2026.